Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
438 studies found for:    "Cutaneous T-cell lymphoma"
Show Display Options
Rank Status Study
1 Unknown  Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma
Condition: Cutaneous T Cell Lymphoma
Intervention: Drug: Lenalidomide
2 Recruiting Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL)
Condition: Cutaneous T Cell Lymphoma
Intervention: Drug: Micro needle array-Doxorubicin (MNA-D)
3 Completed Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
Condition: Cutaneous T-Cell Lymphoma
Intervention: Drug: Panobinostat
4 Terminated Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma
Condition: Cutaneous T-Cell Lymphoma
Intervention: Procedure: skin biopsy
5 Withdrawn Trial of Curcumin in Cutaneous T-cell Lymphoma Patients
Condition: Cutaneous T-cell Lymphoma
Interventions: Drug: Curcumin (Turmeric);   Behavioral: Questionnaires;   Other: Photos
6 Completed A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma
Condition: Cutaneous T-cell Lymphoma
Intervention: Drug: APO866
7 Completed Study of Oral LBH589 in Adult Patients With Refractory/Resistant Cutaneous T-Cell Lymphoma
Condition: Cutaneous T-Cell Lymphoma
Intervention: Drug: LBH589
8 Completed Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Condition: Cutaneous T-cell Lymphoma
Interventions: Drug: Pralatrexate Injection;   Dietary Supplement: Vitamin B12;   Dietary Supplement: Folic Acid
9 Terminated
Has Results
Everolimus in Treating Cutaneous T-cell Lymphoma
Condition: Cutaneous T-Cell Lymphoma
Intervention: Drug: Everolimus
10 Recruiting A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
Condition: Persistent or Recurrent Cutaneous T-Cell Lymphoma
Intervention: Drug: E7777
11 Completed A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma
Condition: Cutaneous T-Cell Lymphoma
Intervention: Drug: Enzastaurin
12 Unknown  Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study
Condition: Cutaneous T-Cell Lymphoma
Intervention: Drug: Tazarotene
13 Recruiting Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma
Condition: Cutaneous T-cell Lymphoma
Interventions: Drug: Romidepsin;   Drug: Poly ICLC;   Radiation: Focal lesional radiation
14 Withdrawn Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)
Condition: Cutaneous T-cell Lymphoma (CTCL)
Intervention: Drug: Sirolimus 0.1% Ointment
15 Active, not recruiting Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)
Condition: Cutaneous T Cell Lymphoma
Interventions: Drug: Topical resiquimod 0.06%;   Drug: topical resiquimod 0.03%
16 Completed Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma
Condition: Cutaneous T-Cell Lymphoma
Interventions: Drug: bexarotene;   Device: photopheresis
17 Completed
Has Results
A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)
Condition: Cutaneous T-cell Lymphoma
Intervention: Drug: romidepsin (depsipeptide, FK228)
18 Recruiting Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)
Condition: Cutaneous T-Cell Lymphoma
Intervention: Biological: IPH4102
19 Recruiting Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL)
Condition: Cutaneous T Cell Lymphoma
Intervention: Drug: dimethylfumarate
20 Completed Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)
Condition: Refractory Cutaneous T-cell Lymphoma
Intervention: Drug: bexarotene

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.